343 related articles for article (PubMed ID: 20368557)
21. Lack of association between LIG4 gene polymorphisms and the risk of breast cancer: a HuGE review and meta-analysis.
Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
Asian Pac J Cancer Prev; 2012; 13(7):3417-22. PubMed ID: 22994770
[TBL] [Abstract][Full Text] [Related]
22. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
23. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
24. Predictors of Survival in Turkish Patients with Primary Glioblastoma.
Bilgin E; Duman BB; Altintas S; Cil T; Gezercan Y; Okten AI
Turk Neurosurg; 2021; 31(4):641-653. PubMed ID: 33759174
[TBL] [Abstract][Full Text] [Related]
25. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Lu J; Cowperthwaite MC; Burnett MG; Shpak M
PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
[TBL] [Abstract][Full Text] [Related]
26. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
[TBL] [Abstract][Full Text] [Related]
27. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk.
Sakiyama T; Kohno T; Mimaki S; Ohta T; Yanagitani N; Sobue T; Kunitoh H; Saito R; Shimizu K; Hirama C; Kimura J; Maeno G; Hirose H; Eguchi T; Saito D; Ohki M; Yokota J
Int J Cancer; 2005 May; 114(5):730-7. PubMed ID: 15609317
[TBL] [Abstract][Full Text] [Related]
28. The clinical characteristics and prognostic factors of multiple lesions in glioblastomas.
Tunthanathip T; Sangkhathat S; Tanvejsilp P; Kanjanapradit K
Clin Neurol Neurosurg; 2020 Aug; 195():105891. PubMed ID: 32480195
[TBL] [Abstract][Full Text] [Related]
29. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
30. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
31. ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.
Guo Q; Guo P; Mao Q; Lan J; Lin Y; Jiang J; Qiu Y
Med Oncol; 2013 Mar; 30(1):325. PubMed ID: 23377983
[TBL] [Abstract][Full Text] [Related]
32. A novel methylation signature predicts radiotherapy sensitivity in glioma.
Feng Y; Li G; Shi Z; Yan X; Wang Z; Jiang H; Chen Y; Li R; Zhai Y; Chang Y; Zhang W; Yuan F
Sci Rep; 2020 Nov; 10(1):20406. PubMed ID: 33230136
[TBL] [Abstract][Full Text] [Related]
33. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
34. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
[TBL] [Abstract][Full Text] [Related]
35. Pseudoprogression as an adverse event of glioblastoma therapy.
Balaña C; Capellades J; Pineda E; Estival A; Puig J; Domenech S; Verger E; Pujol T; Martinez-García M; Oleaga L; Velarde J; Mesia C; Fuentes R; Marruecos J; Del Barco S; Villà S; Carrato C; Gallego O; Gil-Gil M; Craven-Bartle J; Alameda F;
Cancer Med; 2017 Dec; 6(12):2858-2866. PubMed ID: 29105360
[TBL] [Abstract][Full Text] [Related]
36. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
Burton EC; Lamborn KR; Forsyth P; Scott J; O'Campo J; Uyehara-Lock J; Prados M; Berger M; Passe S; Uhm J; O'Neill BP; Jenkins RB; Aldape KD
Clin Cancer Res; 2002 Jan; 8(1):180-7. PubMed ID: 11801556
[TBL] [Abstract][Full Text] [Related]
37. DNA ligase IV is a potential molecular target in ACNU sensitivity.
Kondo N; Takahashi A; Mori E; Noda T; Su X; Ohnishi K; McKinnon PJ; Sakaki T; Nakase H; Ono K; Ohnishi T
Cancer Sci; 2010 Aug; 101(8):1881-5. PubMed ID: 20487264
[TBL] [Abstract][Full Text] [Related]
38. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
[TBL] [Abstract][Full Text] [Related]
39. Blood-based DNA methylation of DNA repair genes in the non-homologous end-joining (NEHJ) pathway in patient with glioma.
Zhou C; Tang H; Yu J; Zhuang D; Zhang H
Int J Clin Exp Pathol; 2015; 8(8):9463-7. PubMed ID: 26464705
[TBL] [Abstract][Full Text] [Related]
40. Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population.
Namgoong S; Cheong HS; Kim JH; Kim LH; Seo JY; Kang SG; Yoon SJ; Kim SH; Chang JH; Shin HD
PLoS One; 2018; 13(11):e0207660. PubMed ID: 30462709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]